Lopressor injection/black box warning: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Created page with "__NOTOC__ {{{{BASEPAGENAME}} }} {{CMG}} {| style="border: 3px solid #696969;" | style="background: #000000; border: 0px; padding: 20px 20px; width: 800px;" | <center> <font c...")
 
mNo edit summary
 
(5 intermediate revisions by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOEDITSECTION____NOTOC__
{{{{BASEPAGENAME}} }}
{{{{BASEPAGENAME}} }}
{{CMG}}
{{CMG}}


{| style="border: 3px solid #696969;"
FDA Package Insert for '''{{BASEPAGENAME}}''' contains no information regarding <span style="text-transform: capitalize; font-style: italic;">{{SUBPAGENAME}}</span>.
| style="background: #000000; border: 0px; padding: 20px 20px; width: 800px;" |
<center>
<font color="#F8F8FF">'''WARNING'''</font>
</center>
 
<center>
<font color="#F8F8FF" size="1">''See full prescribing information for complete boxed warning.''</font>
</center>
 
<b><font color="#F8F8FF">
''[[Ischemic heart disease|{{fontcolor|#FF0000|Ischemic Heart Disease}}]]'': Following abrupt cessation of therapy with certain beta-blocking agents, exacerbations of angina pectoris and, in some cases, myocardial infarction have occurred. When discontinuing chronically administered Lopressor, particularly in patients with ischemic heart disease, the dosage should be gradually reduced over a period of 1-2 weeks and the patient should be carefully monitored. If angina markedly worsens or acute coronary insufficiency develops, Lopressor administration should be reinstated promptly, at least temporarily, and other measures appropriate for the management of unstable angina should be taken. Patients should be warned against interruption or discontinuation of therapy without the physician’s advice. Because coronary artery disease is common and may be unrecognized, it may be prudent not to discontinue Lopressor therapy abruptly even in patients treated only for hypertension.</font></b>
|}

Latest revision as of 13:06, 21 March 2014

Lopressor injection/black box warning®
Black Box Warning
Adult Indications and Dosage
Pediatric Indications and Dosage
Contraindications
Warnings
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration and Monitoring
IV Compatibility
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient information
Precautions with Alcohol
Look-Alike Drug Names
Drug Shortage Status
Price

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

FDA Package Insert for Lopressor injection contains no information regarding black box warning.

Retrieved from "https://www.wikidoc.org/index.php?title=Lopressor_injection/black_box_warning&oldid=958665"